Oxford University Innovation Q4 2017 and Year-End Update
OUI's quarterly round up of news and data, plus our year-end stats.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
OUI's quarterly round up of news and data, plus our year-end stats.
Oxford University spinout Vaccitech will use investment from GV, Oxford Sciences Innovation and Sequoia China to advance a universal flu vaccine and address other diseases requiring cellular immune activation.
The £13m drug discovery partnership between Oxford University, Oxford Sciences Innovation and Evotec supported 12 new projects in first year of operation.
Oxford spinout Oxehealth secures £3m in early-stage funding backed by IP Group.
Augmented and virtual reality spinout 6Degrees revealed as 150th spinout firm from Oxford University.
Oxford’s early-stage EIS/SEIS fund returns to take advantage of new benefits to investors in high tech firms unveiled in the budget.
Gene therapy spinout Nightstar Therapeutics signs deal with Oxford University Innovation to tackle Stargardt disease.
Alex McCallion, Oxford University graduate and research assistant at the Saïd Business School, is launching a crowdfunding campaign to develop a mobile phone app that will help people leave homelessness behind for good.
Oxford University Innovation’s digital health deal with Drayson Technologies and Oxford University Hospitals celebrated at annual OBN awards.
Find out more about what's going on in the Oxford innovation ecosystem with our quarterly report.